Sensorcaine Mpf With Epinephrine
NDC Package 0186-1027-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sensorcaine Mpf With Epinephrine is a . Marketed by Astrazeneca Pharmaceuticals Lp, this product is identified by NDC 0186-1027 and is authorized under FDA application ANDA018304.

Identification & Billing

NDC Package Code
0186-1027-01
Package Description
1 VIAL, MULTI-DOSE in 1 CARTON / 50 mL in 1 VIAL, MULTI-DOSE
Product Code
0186-1027
11-Digit Billing Format
00186102701

Clinical Specifications

Proprietary Name
Sensorcaine Mpf With Epinephrine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Astrazeneca Pharmaceuticals Lp
FDA Application #
ANDA018304
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-1990
End Marketing Date
04-30-2012
Listing Expiration
04-30-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0186-1027-01 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 50 ml in 1 vial, multi-dose of Sensorcaine Mpf With Epinephrine, labeled by Astrazeneca Pharmaceuticals Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Astrazeneca Pharmaceuticals Lp on September 30, 1990. The current certification is valid through April 30, 2012.

How is this Astrazeneca Pharmaceuticals Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00186102701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0186-1027-01
11-Digit CMS (5-4-2)
00186-1027-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.